FBInvestor
Stocks / Merrimack Pharmaceuticals Inc Com
Institutional Ownership

Merrimack Pharmaceuticals Inc Com

CUSIP 590CVR209RIGQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon